Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay

This publication has 14 references indexed in Scilit:

• Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum
  Journal of Pharmaceutical and Biomedical Analysis, 2005
• Single‐Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen‐Activated Protein Kinase Inhibitor: A First‐in‐Human Study
  The Journal of Clinical Pharmacology, 2003
• Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation
  British Journal of Clinical Pharmacology, 2002
• The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic β-cell O-GlcNAc-selective N-acetyl-β-d-glucosaminidase
  Biochemical Journal, 2001
• Measurement of MAP kinase activation by flow cytometry using phospho‐specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors
  Cytometry, 2001
• IMPAIRED EX VIVO LIPOPOLYSACCHARIDE-STIMULATED WHOLE BLOOD TUMOR NECROSIS FACTOR PRODUCTION MAY IDENTIFY “SEPTIC” INTENSIVE CARE UNIT PATIENTS
  Shock, 2000
• A Modified Method of Islet Isolation Preserves the Ability of Pancreatic Islets to Increase Protein O-Glycosylation in Response to Glucose and Streptozotocin
  Archives of Biochemistry and Biophysics, 2000
• Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
  JAMA, 1999
• Determination of tumour necrosis factor-α and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation
  Journal of Immunological Methods, 1998
• A whole-blood technique for testing production of human interferon by leukocytes
  Journal of Immunological Methods, 1982